Exploring Outcomes of Extended Infusions for Gram-Negative Bacteremia
May 14th 2019As clinician are growing interested in the use of extended infusion beta-lactams for gram-negative bacteremia, a team of investigators noticed that available data are unclear and solely focus on clinical cure and/or mortality outcomes.
Oseltamivir Pre-Exposure Prophylaxis Does Not Cut Influenza Rates in Lung Transplant Recipients
May 10th 2019A team of investigators from the University of North Carolina Medical Center found that oseltamivir prophylaxis did not reduce the rate of influenza within the first year following a lung transplant.
Piperacillin/Tazobactam Use in Extended-Spectrum Beta-Lactamase Infections
May 10th 2019The primary outcome of the study, which seeks to fully assess infection-related clinical outcomes and microbiological cure rates of PZT for ESBL infections, was clearance of the causative organism from index infection site on first follow-up culture.
AUC-Based Vancomycin Monitoring Does Not Result in Higher Total Costs for MRSA Bacteremia
May 10th 2019A study at SUNY Upstate University Hospital found that AUC-based vancomycin monitoring does not result in higher total drug and monitoring cost compared to trough-based monitoring for patients with MRSA bacteremia.